United States Diabetes Device Market Forecast Report 2024-2032: Economic Burden of Diabetes Soars to $412.9 Billion, Underlining Need for Effective Management Solutions
28 nov. 2024 06h18 HE
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "United States Diabetes Device Market Forecast Report by Types, End-user, Distribution Channel and Company Analysis 2024-2032" report has been added to ...
France Diabetes Devices Market Report (2024-2032) with Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom
15 oct. 2024 09h13 HE
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "France Diabetes Device Market Forecast Report by Types, Distribution Channel and Company Analysis 2024-2032" report has been added to ...
12-month real-world achievements for Diabeloop's AID
21 sept. 2022 02h00 HE
|
Diabeloop SA
PARIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- EASD 2022 - Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports today on 12 months of use of its hybrid closed-loop DBLG1 System on a...
Diabeloop - Key Player in Therapeutic AI Applied to Insulin Delivery - Announces 70 Million Euros New Financing Round to Accelerate Its International Expansion
02 juin 2022 08h30 HE
|
Diabeloop SA
PARIS, June 02, 2022 (GLOBE NEWSWIRE) -- Diabeloop secures 70 million euros to pursue its solid and sustained growth strategy. The automated insulin delivery pioneer, develops machine-learning...
Diabeloop Presents New Real-Life Results of DBLG1® System
28 avr. 2022 08h00 HE
|
Diabeloop SA
PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- At ATTD 2022 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in...
Diabeloop Adapts Its Self-Learning, Personalized Insulin Automatization Software to Be Used With Insulin Pens
12 avr. 2022 10h00 HE
|
Diabeloop
PARIS, April 12, 2022 (GLOBE NEWSWIRE) -- Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of...
Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings
17 nov. 2021 19h00 HE
|
Diabeloop SA
TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French company Diabeloop, a pioneer in therapeutic AI, announced today that...